Status:
ACTIVE_NOT_RECRUITING
Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Soroptimist association of Monaco
Conditions:
Pediatric Tumor
Familial Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background. Cancer is the leading cause of death by disease in children. Most pediatric tumors differ from adult tumors in terms of biological and clinical characteristics. In children, the part of ge...
Eligibility Criteria
Inclusion
- The patient has a solid or haematological malignancy, either familial forms or isolated cases diagnosed between the ages of 0 and 17 years.
- The minor patient and both biological parents are available to participate in the study OR
- The adult patient and one or both parents are available to participate in the study.
- The patient's parents must have given their free and informed consent and signed the consent for the minor's participation in the study.
- The patient's parent(s) must have given free and informed consent and the patient of legal age must have signed the consent for participation in the study.
- The patient must be affiliated or beneficiary of a Frrench social security scheme.
Exclusion
- The patient's parents are under guardianship or trusteeship or under legal protection Yes No
- Failure to obtain written informed consent from parents (for themselves and their minor child) after a period of reflection Yes No
- No affiliation to or beneficiary of a French social security scheme (for biological parents and the patient)
Key Trial Info
Start Date :
July 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04471961
Start Date
July 9 2020
End Date
December 31 2026
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, Occitanie, France, 34295